Christopher Cianci

1.8k citations

38 papers · 1.1k indexed · h-index 21

Impact in

Epidemiology top 5%
- Influenza Virus Research Studies
- Respiratory viral infections research
Virology top 10%

Papers in

Virology 5
- HIV Research and Treatment 5
Epidemiology 27
- Influenza Virus Research Studies 14
- Respiratory viral infections research 11
- Virology and Viral Diseases 6
- Herpesvirus Infections and Treatments 5

Co-authors: Mark Krystal Nicholas A. Meanwell Laurence Tiley Richard J. Colonno Moira Hagen Kuo‐Long Yu Guangxiang Luo Rita L. Civiello
Journals: Bioorganic & Medicinal Chemistry Letters (11 papers)Journal of Medicinal Chemistry (3 papers)Journal of Virology (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)Antiviral chemistry & chemotherapy (2 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Christopher Cianci

38 papers receiving 1.1k citations

Peers

Countries citing papers authored by Christopher Cianci

Since Specialization

Citations

This map shows the geographic impact of Christopher Cianci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Cianci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Cianci more than expected).

Fields of papers citing papers by Christopher Cianci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Cianci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Cianci. The network helps show where Christopher Cianci may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher Cianci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Cianci Line = papers co-authored together Christopher Cianci links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Design, Synthesis, and Preclinical Profiling of GSK3739936 (BMS-986180), an Allosteric Inhibitor of HIV-1 Integrase with Broad-Spectrum Activity toward 124/125 Polymorphs Journal of Medicinal Chemistry ·B. Narasimhulu Naidu, Manoj Patel, Brian McAuliffe, Bo Ding, Christopher Cianci, 池田信子, Susan Jenkins, Dawn D. Parker, Prasanna Sivaprakasam, Javed Khan, Kevin Kish, H.A. Lewis, Umesh Hanumegowda, Mark Krystal, Nicholas A. Meanwell, John F. Kadow	2022	8
2	Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors Bioorganic & Medicinal Chemistry Letters ·Manoj Patel, Christopher Cianci, Esther Hernández Sainz; Universidad de Zaragoza - Derecho Mercantil, Dawn D. Parker, 池田信子, Susan Jenkins, Brian McAuliffe, Beatrice Minassian, Linda Discotto, Mark Krystal, Nicholas A. Meanwell, B. Narasimhulu Naidu	2020	10
3	Respiratory syncytial virus fusion inhibitors. Part 7: Structure–activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo Bioorganic & Medicinal Chemistry Letters ·Ny Sin, Brian L. Venables, Keith D. Combrink, H. Belgin Gülgeze, Kuo‐Long Yu, Rita L. Civiello, Jan Willem Thuring, Jennifer M. Belcher, Zheng Yang, Lisa Zadjura, Anthony M. Marino, Kathleen F. Kadow, Christopher Cianci, Gaston Michel, Eugene V. Genovesi, Ivette Medina, Lucinda Lamb, Mark Krystal, Nicholas A. Meanwell	2009	36
4	Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activity Bioorganic & Medicinal Chemistry Letters ·P.A. Filistev, Christopher Cianci, Kuo‐Long Yu, Keith D. Combrink, Jan Willem Thuring, Yi Zhang, Rita L. Civiello, Kathleen F. Kadow, Dr.G. Ranganathan, Zhufang Li, David R. Langley, Mark Krystal, Nicholas A. Meanwell	2007	22
5	Respiratory syncytial virus fusion inhibitors. Part 6: An examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety Bioorganic & Medicinal Chemistry Letters ·Keith D. Combrink, H. Belgin Gülgeze, Jan Willem Thuring, Kuo‐Long Yu, Rita L. Civiello, Yi Zhang, Bradley C. Pearce, Zhiwei Yin, David R. Langley, Kathleen F. Kadow, Christopher Cianci, Zhufang Li, Gaston Michel, Eugene V. Genovesi, Ivette Medina, Lucinda Lamb, Zheng Yang, Lisa Zadjura, Mark Krystal, Nicholas A. Meanwell	2007	31
6	Antiviral activity and molecular mechanism of an orally active respiratory syncytial virus fusion inhibitor Journal of Antimicrobial Chemotherapy ·Christopher Cianci, Nicholas A. Meanwell, Mark Krystal	2005	48
7	Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo Bioorganic & Medicinal Chemistry Letters ·Kuo‐Long Yu, P.A. Filistev, Rita L. Civiello, Ashok K. Trehan, Bradley C. Pearce, Zhiwei Yin, Keith D. Combrink, H. Belgin Gülgeze, Yi Zhang, Kathleen F. Kadow, Christopher Cianci, Gaston Michel, Eugene V. Genovesi, Ivette Medina, Lucinda Lamb, Philip R. Wyde, Mark Krystal, Nicholas A. Meanwell	2005	31
8	Respiratory syncytial virus inhibitors. Part 2: Benzimidazol-2-one derivatives Bioorganic & Medicinal Chemistry Letters ·Kuo‐Long Yu, Yi Zhang, Rita L. Civiello, Ashok K. Trehan, Bradley C. Pearce, Zhiwei Yin, Keith D. Combrink, H. Belgin Gülgeze, P.A. Filistev, Kathleen F. Kadow, Christopher Cianci, Mark Krystal, Nicholas A. Meanwell	2004	24
9	Fundamental structure–Activity relationships associated with a new structural class of respiratory syncytial virus inhibitor Bioorganic & Medicinal Chemistry Letters ·C. H. Wang, Yi Zhang, Rita L. Civiello, Kathleen F. Kadow, Christopher Cianci, Mark Krystal, Nicholas A. Meanwell	2003	55
10	Development of a photoaffinity label for respiratory syncytial virus inhibitors Journal of Labelled Compounds and Radiopharmaceuticals ·Douglas D. Dischino, Christopher Cianci, Rita L. Civiello, Mark Krystal, Nicholas A. Meanwell, Hiromi Morimoto, Philip G. Williams, Kuo‐Long Yu	2003	5
11	Structure–activity relationships for a series of thiobenzamide influenza fusion inhibitors derived from 1,3,3-Trimethyl-5-hydroxy-cyclohexylmethylamine Bioorganic & Medicinal Chemistry Letters ·C. H. Wang, Albert Torri, Guangxiang Luo, Christopher Cianci, N. Mikhailov, Van Der Merwe Wc, B. Ninet, Mark Krystal, Nicholas A. Meanwell	2002	44
12	An approach to the identification of potent inhibitors of influenza virus fusion using parallel synthesis methodology Bioorganic & Medicinal Chemistry Letters ·Milind Deshpande, Jianmei Wei, Guangxiang Luo, Christopher Cianci, Van Der Merwe Wc, Al F. Torri, Laurence Tiley, Mark Krystal, C. H. Wang, Stella Huang, Qi Gao, Nicholas A. Meanwell	2001	27
13	Salicylamide inhibitors of influenza virus fusion Bioorganic & Medicinal Chemistry Letters ·Keith D. Combrink, H. Belgin Gülgeze, Kuo‐Long Yu, Bradley C. Pearce, Ashok K. Trehan, Jianmei Wei, Milind Deshpande, Mark Krystal, Albert Torri, Guangxiang Luo, Christopher Cianci, Van Der Merwe Wc, Laurence Tiley, Nicholas A. Meanwell	2000	17
14	Development of antivirals against influenza Expert Opinion on Investigational Drugs ·Christopher Cianci, Mark Krystal	1998	12
15	Differential effect of modified capped RNA substrates on influenza virus transcription Virus Research ·Christopher Cianci, Richard J. Colonno, Mark Krystal	1997	6
16	Inhibition of the influenza virus RNA-dependent RNA polymerase by antisera directed against the carboxy-terminal region of the PB2 subunit Journal of General Virology ·Vivian Blok, Christopher Cianci, A.J. Saur, Stephen Inglis, Mark Krystal, Paul Digard	1996	38
17	Inhibition of herpes simplex virus type 1 DNA polymerase by the natural product oosporein. The Journal of Antibiotics ·Brian Terry, Wen‐Chih Liu, Christopher Cianci, AL Nunes Diniz, Prabhavathi Fernandes, Karen Bush, E.A. Meyers	1992	19
18	Synthesis and antiviral activity of enantiomeric forms of cyclobutyl nucleoside analogs Journal of Medicinal Chemistry ·Gregory S. Bisacchi, Elena Pavlovna Nemirovskaya, Christopher Cianci, Junius M. Clark, Anjalie Field, Moira Hagen, H. Kassymkhanova, Mary F. Malley, Toomas Mitt	1991	79
19	Neutralization of purified herpes simplex virus DNA polymerase by two antipeptide sera Virus Genes ·James T. Matthews, John T. Stevens, Brian Terry, Christopher Cianci, M L Haffey	1990	4
20	ATP‐Dependent Gelation Contraction of Microtubules in Vitro Annals of the New York Academy of Sciences ·Christopher Cianci, Daniel Hijosa-Guzmán, Baochong Gao, Richard C. Weisenberg	1986	9

About Christopher Cianci

Christopher Cianci is a scholar working on Virology, Epidemiology, Pharmaceutical Science, Infectious Diseases and Immunology, having authored 38 papers that have together received 1.1k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (14 papers), Respiratory viral infections research (11 papers), Plant Virus Research Studies (7 papers), Virology and Viral Diseases (6 papers), RNA and protein synthesis mechanisms (6 papers), HIV Research and Treatment (5 papers), interferon and immune responses (5 papers) and Herpesvirus Infections and Treatments (5 papers). The work is most often cited by research in Epidemiology (652 citations), Virology (67 citations), Infectious Diseases (238 citations), Organic Chemistry (278 citations) and Molecular Biology (433 citations). Christopher Cianci has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Mark Krystal, Nicholas A. Meanwell, Laurence Tiley, Richard J. Colonno, Moira Hagen, Kuo‐Long Yu, Guangxiang Luo, Rita L. Civiello, Brian Terry and Kathleen F. Kadow. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Virology, Antimicrobial Agents and Chemotherapy and Antiviral chemistry & chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact